A Phase II Study of Pembrolizumab in Combination with Capecitabine and Oxaliplatin with Molecular Profiling in Patients with Advanced Biliary Tract Carcinoma.
Cecilia MongeErica C PehrssonChangqing XieAustin G DuffyDonna MabryBradford J WoodDavid E KleinerSeth M SteinbergWilliam Douglas FiggBernadette ReddAnuradha BudhuSophie WangMayank TandonLichun MaXin Wei WangTim F GretenPublished in: The oncologist (2022)
This study was registered in ClinicalTrials.gov (NCT03111732).